查詢結果分析
來源資料
相關文獻
- Prognostic Value of Serial Serum Prostate-Specific Antigen Measurements in Metastatic Prostate Cancer Patients Treated with Androgen Ablation
- Morbidity with Contemporary Transrectal Biopsy of the Prostate
- The Role of Percent Free-Prostate Specific Antigen (PSA) in Patients with Total PSA Levels between 4.0 and 10.0 ng/ml
- Application of Cryoablation in the Management of Prostate Cancer
- 前列腺特異抗原--篩檢前列腺癌的利器
- Phase Ⅱ Clinical Trial of Monthly Triptorelin Injection for Prostate Cancer
- Differentiation of Prostate Adenocarcinoma from Benign Prostatic Hyperplasia Using Prostate Specific Antigen Density (PSAD)
- Diagnosis of Prostate Cancer: Comparison of Serum Prostate Specific Antigen, Digital Rectal Examination and Transrectal Ultrasonography
- 前列腺特異抗原--篩檢前列腺癌的利器
- Distribution of Serum Prostate-Specific Antigen in Healthy Chinese Men
第1筆 /總和 1 筆
/ 1 筆
頁籤選單縮合
題名 | Prognostic Value of Serial Serum Prostate-Specific Antigen Measurements in Metastatic Prostate Cancer Patients Treated with Androgen Ablation=血中前列腺特異抗原變化在接受男性荷爾蒙去除療法的轉移前列腺癌患者的預後意義 |
---|---|
作者 | 蔡育賢; 蔡宗欣; 林信男; 唐一清; 楊文宏; 張建成; 鄭鴻琳; 林永明; Tsai, Yuh-shyan; Tzai, Tzong-shin; Lin, Johnny SN; Tong, Yat-ching; Yang, Wen-horng; Chang, Chien-chen; Cheng, Hong-lin; Lin, Yung-ming; |
期刊 | 臺灣泌尿科醫學會雜誌 |
出版日期 | 20050600 |
卷期 | 16:2 民94.06 |
頁次 | 頁65-73 |
分類號 | 416.275 |
語文 | eng |
關鍵詞 | 前列腺癌; 前列腺特異抗原; 男性荷爾蒙去除療法; Prostatic neoplasm; Prostatic-specific antigen; Androgen ablation; |